Sartorius AGSARTF -1.83%85 Pretax Margin % is 12.35% as of Mar. 2026, which is 23% below its 10-year median of 16.14. GuruFocus rates SARTF with a GF Score™ of 85/100 and a GF Value™ of $226.12 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Sartorius AG ranks better than 67.44% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Sartorius AG's Pre-Tax Income for the
three
months ended in Mar. 2026 was $128 Mil. Sartorius AG's Revenue for the
three
months ended in Mar. 2026 was $1,039 Mil. Therefore, Sartorius AG's pretax margin for the quarter that ended in Mar. 2026 was 12.35%.
The historical rank and industry rank for Sartorius AG's Pretax Margin % or its related term are showing as below:
SARTF'
s Pretax Margin % Range Over the Past 10 Years
Min: 5.53 Med: 16.14 Max: 28.31
Current: 9.81
SARTF's Pretax Margin % is ranked better than 67.44% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.43
vs SARTF: 9.81
Sartorius AG (OTCPK:SARTF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Sartorius AG Pretax Margin % Related Terms
Sartorius AG Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Sartorius AG's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SARTF vs ISRG, BDX, MDLN: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, Sartorius AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sartorius AG Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Sartorius AG's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sartorius AG (SARTF) has a Pretax Margin % of 12.35% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sartorius AG and its competitors. This is 23% below median its historical median of 16.14. Over the past decade, Sartorius AG's Pretax Margin % has ranged from 5.53 to 28.31. According to the industry distribution chart, Sartorius AG ranks #266 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 32.6%.
Is Sartorius AG's Pretax Margin % too high?
Sartorius AG's current Pretax Margin % of 12.35% is 23% below median its 10-year median of 16.14. Over the past 10 years, this metric has ranged from a low of 5.53 to a high of 28.31. The Medical Devices & Instruments industry median Pretax Margin % is 2.43. Sartorius AG's value of 12.35% is 408.2% above this industry median. Based on the distribution chart, Sartorius AG ranks #266 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sartorius AG has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sartorius AG's Pretax Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sartorius AG ranks #266 out of 817 companies for Pretax Margin %. This puts Sartorius AG in the upper half of its industry. The industry median Pretax Margin % is 2.43. Sartorius AG's value of 12.35% is 408.2% above this benchmark. Historically, Sartorius AG's own Pretax Margin % has ranged from 5.53 to 28.31 over the past decade. While the company's 10-year median is 16.14 vs. the industry median of 2.43, Sartorius AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.43, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sartorius AG's current Pretax Margin % of 12.35% is 408.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sartorius AG and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sartorius AG's current Pretax Margin % is 12.35%, which is 23% below median its own 10-year median of 16.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius AG stock overvalued right now?
Based on GuruFocus' analysis, Sartorius AG (SARTF) is currently considered Modestly Undervalued. The stock's GF Value™ is $226.12, compared to a current price of $192.43 — trading 14.9% below its estimated fair value. The current Pretax Margin % is 12.35%, which is 23% below median its 10-year median of 16.14 and 408.2% above the Medical Devices & Instruments industry median of 2.43. Sartorius AG's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Sartorius AG (SARTF), the current Pretax Margin % is 12.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sartorius AG (SARTF) Overvalued in 2026?
Based on GuruFocus' analysis, Sartorius AG stock appears to be undervalued.
The current stock price of $192.43 is trading 14.9% below its estimated GF Value™ of $226.12.
GuruFocus considers Sartorius AG to be Modestly Undervalued.
Key valuation signals for SARTF:
Pretax Margin %: 12.35% (23% below median its 10-year median of 16.14)
GF Value™: $226.12 vs. price of $192.43 (14.9% below fair value)
Industry Position: 408.2% above the Medical Devices & Instruments median (#266 of 817)
No single metric tells the full story. See the SARTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
85GF Score
Get the complete analysis for SARTF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SARTF has been successfully added to your 
